Insider selling
Traded May 7, 2025 · filed 3 days laterNot reported under a pre-arranged trading plan
A major shareholder of Os Therapies sold $164K of Os Therapies shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
OSTX · NYSE · Pharmaceutical Preparations
$0.803−0.0174 (−2.12%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Os Therapies (OSTX) · oqro.io/stocks/OSTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
29 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Insider selling
Traded May 7, 2025 · filed 3 days laterNot reported under a pre-arranged trading plan
A major shareholder of Os Therapies sold $164K of Os Therapies shares. The filing does not indicate a pre-arranged trading plan.
Traded Apr 9 – Apr 10, 2025 · largest single transaction ~$68KNot reported under a pre-arranged trading plan
Apr 9, 2025~$68K · 50K sh @ $1.35
DetailsInsider selling
Traded Feb 14, 2025 · filed 5 days laterNot reported under a pre-arranged trading plan
A major shareholder of Os Therapies sold $284K of Os Therapies shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Jan 15, 2025 · filed 3 days laterNot reported under a pre-arranged trading plan
A major shareholder of Os Therapies sold $113K of Os Therapies shares. The filing does not indicate a pre-arranged trading plan.
Apr 10, 2025~$14K · 10K sh @ $1.39
DetailsOfficial record0 open-market purchases and 5 open-market sales by insiders of OSTX between Oct 16, 2024 and today, placed against the company's last 4 earnings releases. The latest on file was filed Aug 19, 2025.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Aug 19, 2025 | None | None | None |
| May 16, 2025 | 1 sale | None | None |
| Mar 31, 2025 | None | None | 2 sales |
| Nov 15, 2024 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies